Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011570 (
depression
)
172,036
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
To ascertain whether the long cardiac pauses on the Holter ECGs of patients with the
sick sinus syndrome
were related to the spontaneously occurring overdrive suppression, the heart rates for the 12 seconds preceding the cardiac pauses longer than 5 seconds were compared with that averaged for 24 hours. Even in six out of seven patients with bradycardia-tachycardia syndrome the former rate was not significantly greater than the latter, indicating that episodes of such long cardiac pauses may not result from spontaneously occurring overdrive suppression. This observation was also consistent with the result that no statistically significant correlation was obtained between the maximum pauses measured from Holter ECGs of
sick sinus syndrome
and those obtained by the overdrive suppression test. In conclusion, many episodes of long life-threatening cardiac pauses observed in
sick sinus syndrome
may be attributed to accidental
depression
of the sinus nodal and subsidiary pacemaker activity rather than to spontaneously occurring overdrive suppression; therefore, Holter monitoring may be useful as an additional tool for diagnosis of
sick sinus syndrome
.
...
PMID:Comparative evaluation of depressed automaticity in sick sinus syndrome by Holter monitoring and overdrive suppression test. 668 81
To improve methods for evaluating human sinus node function (SNF), we developed a transvenous electrode catheter technique for direct recording of sinus node electrograms in adults. Sinus node electrograms (SNE) characterized by low-frequency, anatomically localized pre-P-wave potentials were obtained in 19 of 23 patients. The SNE configuration was similar to that previously found for endocardial SNE recordings in in vitro atrial preparations, in open-chest dogs and during human open heart surgery. In 16 patients with normal SNF, directly recorded sinoatrial conduction times (SACTs) were 46-116 msec. In three patients with
sick sinus syndrome
, SACT was 110-126 msec. In 15 of the 19 patients, SACT was estimated by the atrial premature stimulus technique and was compared with the directly measured SACT. When atrial premature depolarizations produced no sinus node
depression
, the mean differences between the direct and estimated SACT was 1.8 +/- 5.6 msec.
...
PMID:The human sinus node electrogram: a transvenous catheter technique and a comparison of directly measured and indirectly estimated sinoatrial conduction time in adults. 743 68
The electrophysiologic effects of diltiazem, a calcium antagonistic agent, were studied in 30 subjects with various degrees of sinus or AV node dysfunction. After diltiazem was administered, sinus activity was not depressed in control subjects, whereas marked inhibition was observed in some of the patients with
sick sinus syndrome
. Ventricular automaticity was little affected by this drug. The AV conduction system was significantly depressed, and there was no difference in degree between controls and AV block patients. The
depression
of the AV conduction system became more marked as the basic atrial cycle length was shortened. The drug had no apparent effects on atrial refractoriness, atrial echo zone, or the accessory pathway system. Conclusively, diltiazem affects mainly sinus and AV conduction systems. Its effect on the sinus mode may provide a hazardous problem in patients with the sick sinus sysdrome patients, while its effect on the AV node will have therapeutic value in patients with AV nodal re-entrant arrhythmias.
...
PMID:Electrophysiologic effects of diltiazem, a calcium antagonist, in patients with impaired sinus or atrioventricular node function. 744 77
An atrial-based pacing mode is superior to ventricular constant rate demand pacing (VVI) mode in patients with
sick sinus syndrome
(SSS) by providing both rate adaptation and atrioventricular (AV) synchrony. The use of a non-atrial sensor to overcome chronotropic incompetence and preserve normal intrinsic AV conduction in pacemaker therapy for SSS was investigated in 15 consecutive patients (mean age 66 +/- 2 years). All had intact AV conduction (antegrade conduction capacity > 100 beats.min-1 and an atrial paced to intrinsic R interval of < or = 220 ms). DDDR pacemakers capable of being programmed into atrial rate adaptive (AAIR), dual chamber rate adaptive (DDDR) and ventricular rate adaptive (VVIR) modes were used. Beginning with an acute study, arterial pressure was invasively assessed in each pacing mode during physiological stresses and low level exercise. In the ambulatory phase, the incidence of ventricular pacing and arrhythmias (Holter recording), diurnal blood pressure changes (ambulatory blood pressure recording), and symptom and quality of life level (questionnaires and interviews) were compared. Despite similar heart rate changes during acute physiological stresses, a higher blood pressure was recorded during AAIR or DDDR pacing compared with VVIR pacing. Systolic blood pressure over 24 h was lower in the VVIR mode (122 +/- 5 mmHg) than AAIR/DDDR pacing (129 +/- 6/128 +/- 6 mmHg, P < 0.05). VVIR pacing was associated with a higher frequency of atrial and ventricular ectopics, with two patients developing paroxysmal atrial fibrillation. Ventricular pacing was used in a higher percentage in the DDDR compared with the VVIR mode (64 +/- 11 and 39 +/- 7%, P < 0.03). VVIR pacing was associated with more palpitations, a lower level of general well being and
depression
. Despite the use of a sensor to overcome chronotropic incompetence, VVIR pacing is a less satisfactory pacing mode for SSS. Although AAIR/DDDR pacing may achieve similar haemodynamic and clinical status, in patients with intact AV conduction, AAIR pacing may be preferable by avoiding an abnormal ventricular activation pattern.
...
PMID:Rate adaptive pacing in sick sinus syndrome: effects of pacing modes and intrinsic conduction on physiological responses, arrhythmias, symptomatology and quality of life. 783 58
Beta blockers in patients with
sick sinus syndrome
(SSS) may prevent supraventricular arrhythmias, systemic hypertension and myocardial ischemia, but may cause excessive
depression
of sinus node function. In 8 patients with SSS and a permanent pacemaker, the effect of chronic oral pindolol on sinus rate and pacing frequency was compared with that of propranolol in a double-blind crossover trial. In all patients the pacemaker was programmed to a rate of < or = 50 beats/min. Holter monitors, obtained at baseline and on each drug, were used to calculate peak ambulatory sinus rate, number of paced beats per day, maximal number of paced beats per hour, and percentage of hours with paced beats. The peak sinus rate with pindolol therapy was 24% higher than with propranolol (p = 0.001). During pindolol therapy, the number of paced beats per day and maximal paced beats per hour were reduced 54% (p = 0.04) and 61% (p = 0.02), respectively, compared with propranolol. Patients with SSS who require beta-blocker therapy for tachycardia, systemic hypertension or angina pectoris may have less bradycardia when treated with pindolol rather than propranolol. Beta blockers like pindolol, which cause less sinus node
depression
, may obviate the need for prophylactic permanent pacemakers in patients with SSS, and may help to prevent chronotropic incompetence and pacemaker syndrome in patients already treated with a VVI device.
...
PMID:Comparison of effects of propranolol versus pindolol on sinus rate and pacing frequency in sick sinus syndrome. 842 Feb 36
<< Previous
1
2